Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Mar;61(2):282-285.
doi: 10.5468/ogs.2018.61.2.282. Epub 2018 Feb 13.

A rare melanoma feature with primary ovarian origin: a case report and the literature review

Affiliations
Case Reports

A rare melanoma feature with primary ovarian origin: a case report and the literature review

Algeri Paola et al. Obstet Gynecol Sci. 2018 Mar.

Erratum in

  • Erratum: Author Corrections.
    [No authors listed] [No authors listed] Obstet Gynecol Sci. 2018 Sep;61(5):645. doi: 10.5468/ogs.2018.61.5.645. Epub 2018 Aug 10. Obstet Gynecol Sci. 2018. PMID: 30255004 Free PMC article.

Abstract

Primary ovarian melanoma arising on a mature ovarian cystic teratoma is extremely rare. As best of our knowledge, to date, 49 cases have been reported in literature. Few information was reported about best management and therapy. We present a case occurred in a 69-year-old woman, without symptoms, who come to our unit for stress incontinence. A pelvic mass was detected and, after imaging evaluation, surgery was performed. The diagnosis was ovarian melanoma arose on a mature teratoma. No other adjuvant treatment was proposed after surgery. She died 9 months after the first diagnosis. Primary ovarian melanoma is a definite entity associated with a variable natural history and poor prognosis. Differential diagnosis is a challenge for the pathologist, because it must be differentiated by metastatic melanoma. The corner stone treatment of this disease is surgery; however, chemotherapy, immunotherapy, and target therapy seem to have a role.

Keywords: Melanoma; Ovarian cancer; Teratoma.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1
(A) cyst wall (original magnification ×10). (B) hematoxylin-eosin (original magnification ×40). (C) hematoxylin-eosin with brown pigment (original magnification ×40). (D) Immunostain for Melan A shows a diffuse, intensively cytoplasmic positive reaction.

References

    1. O'Gorman T, Olaitan A. Primary malignant melanoma arising in an ovarian cystic teratoma. Eur J Gynaecol Oncol. 2009;30:88–89. - PubMed
    1. Sugiyama VE, Chan JK, Kapp DS. Management of melanomas of the female genital tract. Curr Opin Oncol. 2008;20:565–569. - PubMed
    1. Andrews HR. Primary Melanotic sarcoma of the ovary. Trans Obstet Soc (Lond) 1901;43:228–231.
    1. Moore RG, Chung M, Granai CO, Gajewski W, Steinhoff MM. Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol. 2004;93:87–91. - PubMed
    1. Cronje HS, Woodruff JD. Primary ovarian malignant melanoma arising in cystic teratoma. Gynecol Oncol. 1981;12:379–383. - PubMed

Publication types